Thomas W. Dubensky, Chief Scientific Officer at ADURO BIOTECH, INC. (ADRO), sold 25,000 shares at $14.03 ($351K) on 2016-09-01, disclosed to the SEC on 2016-09-02.
Scheduled sale ($351k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADRO | SELL | 2017-07-06 | $567K | — | Filing → |
| ADRO | SELL | 2017-06-05 | $1.4M | — | Filing → |
| ADRO | SELL | 2017-05-15 | $57K | — | Filing → |